Inducible tissue constructs and uses thereof
US-2024287463-A1 · Aug 29, 2024 · US
US2018024116A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018024116-A1 |
| Application number | US-201715648213-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jul 12, 2017 |
| Priority date | Jul 12, 2016 |
| Publication date | Jan 25, 2018 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compositions, devices and methods are described for improving adhesion, attachment, and/or differentiation of cells in a microfluidic device or chip. In one embodiment, one or more ECM proteins are covalently coupled to the surface of a microchannel of a microfluidic device. The microfluidic devices can be stored or used immediately for culture and/or support of living cells such as mammalian cells, and/or for simulating a function of a tissue, e.g., a liver tissue, muscle tissue, etc. Extended adhesion and viability with sustained function over time is observed.
Opening claim text (preview).
We claim: 1 . A method of culturing cells, comprising: a) providing a microfluidic device comprising a microchannel comprising a surface, said microchannel in fluidic communication with a fluid source comprising fluid; b) covalently attaching one or more proteins or peptides to said microchannel surface so as to create a treated surface; c) seeding viable cells on said treated surface so as to create attached cells; c) flowing fluid from said fluid source through said microchannel so as to create flowing conditions; and d) culturing said attached cells under said flow conditions such that said cells remain attached and viable for at least 14 days. 2 . The method of claim 1 , wherein said cells are hepatocytes. 3 . The method of claim 2 , further comprising e) assessing viability by measuring the level of activity of one or more cellular enzymes. 4 . The method of claim 3 , wherein said cellular enzyme is a CYP enzyme. 5 . The method of claim 3 , wherein said cellular enzyme is a transaminase. 6 . The method of claim 1 , further comprising e) assessing viability by measuring the level of expression of one or more cellular proteins. 7 . The method of claim 1 , wherein said one or more proteins comprises collagen. 8 . The method of claim 1 , wherein said one or more proteins comprises a mixture of collagen type I, fibronectin and collagen type IV. 9 . The method of claim 1 , wherein said one or more peptides comprises RGD or a peptide comprising the RGD motif. 10 . The method of claim 9 , wherein RGD is covalently attached to said microchannel surface using N-sulphosuccinimidyl-6-(4′-azido-2′-nitrophenylamino) hexanoate. 11 . A method of culturing cells, comprising: a) providing a microfluidic device comprising a microchannel comprising a surface, said microchannel in fluidic communication with a fluid source comprising fluid; b) covalently attaching one or more proteins or peptides to said microchannel surface so as to create a treated surface; c) seeding viable hepatocytes on said treated surface so as to create attached cells; c) flowing fluid from said fluid source through said microchannel so as to create flowing conditions; and d) culturing said attached cells under said flow conditions such that said cells remain attached and viable for at least 14 days. 12 . The method of claim 11 , wherein said hepatocytes are dog hepatocytes. 13 . The method of claim 11 , further comprising e) assessing viability by measuring the level of activity of one or more cellular enzymes. 14 . The method of claim 13 , wherein said cellular enzyme is a CYP enzyme. 15 . The method of claim 13 , wherein said cellular enzyme is a transaminase. 16 . The method of claim 11 , further comprising e) assessing viability by measuring the level of expression of one or more cellular proteins. 17 . The method of claim 11 , wherein said one or more proteins comprise collagen. 18 . The method of claim 11 , wherein said one or more proteins comprises a mixture of collagen type I, fibronectin and collagen type IV. 19 . The method of claim 18 , wherein said mixture is covalently attached to said microchannel surface using N-sulphosuccinimidyl-6-(4′-azido-2′-nitrophenylamino) hexanoate. 20 . The method of claim 11 , wherein said one or more peptides comprises RGD or a peptide comprising the RGD motif. 21 . The method of claim 20 , wherein RGD is covalently attached to said microchannel surface using N-sulphosuccinimidyl-6-(4′-azido-2′-nitrophenylamino) hexanoate. 21 . The method of claim 20 , wherein said microchannel surface is PDMS and is plasma treated prior to step b).
Material Coatings (immunocoatings C12M25/00) · CPC title
for testing toxicity · CPC title
Cross-linking · CPC title
Membranes; Filters (filters or filtration in general B01D24/00-B01D41/00) · CPC title
Hepatocytes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.